医学会议分类导航
 
 
领域国际医学会议网公众号
 
首页  
2023年第20届日本肿瘤内科学会年会(JSMO)
     
 

◆ 会议时间:2023年3月16日至18日
◆ 会议地点:日本 福冈(Fukuoka)

 

◆ 会议简介:

2023年第20届日本肿瘤内科学会(JSMO)年会将于2023年3月16日至18日在日本福冈举行,本次会议预计有6,000多余名代表参加。

日本肿瘤内科学会/日本臨床腫瘍学会(JSMO)的使命是通过改善癌症的治疗,为社会公益事业做出贡献。为了实现这一目标,JSMO每年召开会议和教育项目,支持癌症研究,探索、研究和传播与癌症患者、家庭成员和癌症研究人员的癌症治疗有关的国内和国际信息;宣促进和鼓励改进癌症医疗技术;制定癌症治疗指南,并从事各种业务活动,以保持与相关组织的联系和合作。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com).

2023 the Japanese Society of Medical Oncology Annual Meeting
第20回日本臨床腫瘍学会学術集会(The 20th Annual Meeting of JSMO)

Date March 16 - 18, 2023
Venue Fukuoka International Congress Center/Marine Messe Fukuoka
Theme Cancer, Science and Life
Congress President Eishi BABA

 

摘要征集:

Abstract Submission Period

Noon, Wednesday, June 15, 2022 – Noon, Thursday, September 15, 2022 (JST)

点此提交摘要>>>Submit Abstract>>>

 


 

2023 the Japanese Society of Medical Oncology Annual Meeting (JSMO2023)
Congress President
Eishi Baba, M.D., Ph.D.
Professor, Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University

It is my pleasure to announce that 2023 the Japanese Society of Medical Oncology Annual Meeting (JSMO2023) will be held in a hybrid format at the Fukuoka International Congress Center and Marine Messe Fukuoka in Fukuoka City, Fukuoka Prefecture, on March 16 – 18, 2023.

The Japanese Society of Medical Oncology (JSMO) was officially established as an academic society in 2004 and held its first Annual Meeting in Fukuoka, Japan, under the supervision of the Congress President Dr. Nobuihiko Kuwano. The following main issues were addressed: uniform accessibility of cancer care in Japan, promotion of appropriately designed clinical research and elimination of drug lag, and training of specialized clinical oncologists who play a vital role in these areas. With all the participants taking part in discussions in a single large venue, this meeting was truly a starting point for the future of JSMO. For the last 20 years, cancer treatment in Japan and worldwide has undergone remarkable changes, and the Annual Meeting has evolved with these developments.

For the commemoration of the 20th anniversary of this meeting, the theme “Cancer, Science and Life” is selected to reflect upon the progress that has been achieved. Science-based knowledge is crucial in driving future advances in cancer care and helping patients lead satisfying and rewarding lives. We hope that this meeting will provide an opportunity to share and deepen our understanding of this commitment.

To this end, we eagerly await general abstracts on new breakthroughs that will overturn existing concepts, robust clinical research that will transform future practice, and basic and translational research that will form the basis for cancer care advancements. We also welcome reports of new findings derived from careful observations of daily practice and look forward to presentations from young members with innovative ideas. In addition, we will present abstracts covering a wide range of areas, including supportive care, physical and psychological support in palliative care, patient advocate development, and medical economics to make this forum in strong support of the lifestyles and lives of patients living with cancer through healthcare. In close collaboration with the Scientific Program Committee and the International Affairs Committee, the educational program will feature symposia in which the latest research findings on critical topics, including immunotherapy and cancer genomics, will be presented by Japanese and international researchers. Discussions among experts will deepen participants’ understanding of these topics. Together with the Education Committee, we have also scheduled a program for young physicians aspiring to become cancer pharmacotherapy specialists.

We will actively support participants to ensure that this meeting becomes a focal point for communication and information exchange among researchers from overseas, particularly from Asia. We will further enhance the Patient Advocate Program to encourage patients to attend the meeting and deepen their understanding of the JSMO’s goal of optimal cancer care.

Considering that the COVID-19 situation remains unpredictable, we are taking all possible infection control measures and making adequate preparations to hold the meeting in a hybrid format. It is our hope that many of you will gather to meet face to face and exchange views on the future of cancer care and medical oncology in Fukuoka in March, when the cherry blossoms are in bloom.

We appreciate your warm understanding and support and look forward to welcoming you in Fukuoka.

 


 

 

◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。

 
 
※相关服务※
会议注册服务:30美金起/人/次(服务费)+ 会议注册费(按官方规定收取,注册类别请咨询客服);
出境签证服务:1650元人民币/人/次(美国,含签证费),其它国家咨询客服;
大会投稿服务:30美金/人/次,官方收取费用另计(如有);
会员申请服务:30-100美金/人/次;

团组参会、行程定制,以及需要其它服务(如接送机等),请直接联系客服。


 
咨询报名:
李老师
400-089-1003(微信扫描右侧二维码咨询)
 
 
领域国际医学会议网——专注专业的国际医学会议服务商,专业服务医学相关群体!
 
  领域国际医学会议网介绍/联系  
版权所有:领域国际医学会议网 未经许可禁止复制转载摘录镜像本站任何内容! 隐私政策/版权/免责声明 | 联系我们